SCHEMBL23009276

SCHEMBL23009276

N#CCNS(=O)(=O)N1CCOC1=O

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.33
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28171064 0.84 PARG (0.33)
SCHEMBL22528995 0.76 KDM4E (0.33) KDM4E
SCHEMBL22290089 0.76 NAAA (0.41)
SCHEMBL897720 0.75 KDM4E (0.36) PIK3CDKDM4E
SCHEMBL22339126 0.75 PIK3CD (0.35) PIK3CDKDM4E
SCHEMBL12195850 0.75 ALDH1A1 (0.36) KDM4E
SCHEMBL13158266 0.75 KDM4E (0.34) PIK3CDKDM4E
SCHEMBL1220907 0.74 GBA1 (0.36)
SCHEMBL10252597 0.74 PIK3CD (0.30) PIK3CD
SCHEMBL18109143 0.74 ALDH1A1 (0.36) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112654605-B Bridged heterocyclic group substituted pyrimidine compound and preparation method and medical application thereof 中国医药研究开发中心有限公司 2022-11-22 CN disclosed
EP-4011865-A1 BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF The National Institutes of Pharmaceutical R&D Co., Ltd (CN) 2022-06-15 EP disclosed
WO-2021027647-A1 BRIDGED HETEROCYCLYL-SUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 中国医药研究开发中心有限公司 2021-02-18 WO disclosed